Items related to Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics - Softcover

 
9782817805146: Biosimilars: A New Generation of Biologics

Synopsis

Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the "generic rule" valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of "biological medicinal products similar to a biological reference product", or "biosimilars". This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.

"synopsis" may belong to another edition of this title.

Product Description

‘Biosimilars’ are copies of biological medicinal products no longer protected by certification. Detailing new EU legal and regulatory frameworks on biosimilars, this book also analyzes their safety, marketing, and funding, and includes a section on US rules.

About the Author

Jean-Louis Prugnaud is a pharmacist, former head of pharmacy department at Saint-Antoine Hospital, Paris, France. He is Member of the French Commission of drugs’ distribution authorization, President of the Commission of gene and cellular therapy and President of the pharmaceutical working group on biological and biothechnological drugs. Jean-Hugues Trouvin works at AFSSAPS (French health products safety agency) and at the pharmaceutical and biological sciences department at the Paris Descartes University in Paris, France. Preface: Christian K. Schneider is Chairman, CHMP of the Similar Biological (Biosimilar) Medicinal Products Working Party (BMWP), member of the European Medicines Agency( London, United Kingdom) and works at the Paul-Ehrlich-Institut, Federal Agency for Sera and Vaccines (Langen, Germany) and at the Centre for Experimental and Clinical Infection Research (Hannover, Germany).

"About this title" may belong to another edition of this title.

Buy Used

Condition: As New
Unread book in perfect condition... Learn more about this copy

Shipping: £ 15
From United Kingdom to U.S.A.

Destination, rates & speeds

Add to basket

Other Popular Editions of the Same Title

9782817803357: Biosimilars: A New Generation of Biologics

Featured Edition

ISBN 10:  2817803353 ISBN 13:  9782817803357
Publisher: Springer, 2012
Hardcover

Top Search Results from the AbeBooks Marketplace

Seller Image

Published by Springer, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Soft Cover

Seller: booksXpress, Bayonne, NJ, U.S.A.

Seller rating 4 out of 5 stars 4-star rating, Learn more about seller ratings

Soft Cover. Condition: new. Seller Inventory # 9782817805146

Contact seller

Buy New

£ 98.18
Convert currency
Shipping: FREE
Within U.S.A.
Destination, rates & speeds

Quantity: 10 available

Add to basket

Stock Image

Published by Springer, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Softcover

Seller: Lucky's Textbooks, Dallas, TX, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # ABLIING23Mar3012140348836

Contact seller

Buy New

£ 104.90
Convert currency
Shipping: £ 2.97
Within U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

Prugnaud, Jean-louis (EDT); Trouvin, Jean-hugues (EDT)
Published by Springer, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Softcover

Seller: GreatBookPrices, Columbia, MD, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # 23055067-n

Contact seller

Buy New

£ 105.93
Convert currency
Shipping: £ 1.97
Within U.S.A.
Destination, rates & speeds

Quantity: 5 available

Add to basket

Stock Image

Jean-Louis Prugnaud
Published by Springer, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Softcover
Print on Demand

Seller: Ria Christie Collections, Uxbridge, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9782817805146_lsuk

Contact seller

Buy New

£ 112.66
Convert currency
Shipping: £ 9.98
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

Prugnaud, Jean-louis (EDT); Trouvin, Jean-hugues (EDT)
Published by Springer, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Softcover

Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # 23055067-n

Contact seller

Buy New

£ 112.65
Convert currency
Shipping: £ 15
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: 5 available

Add to basket

Seller Image

Jean-Hugues Trouvin
Published by Springer Paris Dez 2014, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Taschenbuch
Print on Demand

Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the 'generic rule' valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of 'biological medicinal products similar to a biological reference product', or 'biosimilars'. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context. 108 pp. Englisch. Seller Inventory # 9782817805146

Contact seller

Buy New

£ 110.22
Convert currency
Shipping: £ 19.17
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket

Stock Image

Prugnaud, Jean-louis (Editor)/ Trouvin, Jean-hugues (Editor)
Published by Springer Verlag, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Paperback

Seller: Revaluation Books, Exeter, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Paperback. Condition: Brand New. 1st edition. 87 pages. 9.00x6.00x0.25 inches. In Stock. Seller Inventory # x-2817805143

Contact seller

Buy New

£ 121.25
Convert currency
Shipping: £ 10
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket

Seller Image

Prugnaud, Jean-Louis|Trouvin, Jean-Hugues
Published by Springer Paris, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Softcover

Seller: moluna, Greven, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # 4315316

Contact seller

Buy New

£ 91.93
Convert currency
Shipping: £ 40.83
From Germany to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

Jean-Hugues Trouvin
Published by Springer Paris, 2014
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Taschenbuch

Seller: AHA-BUCH GmbH, Einbeck, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the 'generic rule' valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of 'biological medicinal products similar to a biological reference product', or 'biosimilars'. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context. Seller Inventory # 9782817805146

Contact seller

Buy New

£ 111.54
Convert currency
Shipping: £ 27.50
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket

Stock Image

. Ed(s): Prugnaud, Jean-Louis; Trouvin, Jean-Hugues
Published by Springer Editions, 2012
ISBN 10: 2817805143 ISBN 13: 9782817805146
New Softcover

Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. 'Biosimilars' are copies of biological medicinal products no longer protected by certification. Detailing new EU legal and regulatory frameworks on biosimilars, this book also analyzes their safety, marketing, and funding, and includes a section on US rules. Editor(s): Prugnaud, Jean-Louis; Trouvin, Jean-Hugues. Num Pages: 90 pages, 5 black & white tables, biography. BIC Classification: MJCL; MJCM; MJR; MQP; TDCW. Category: (G) General (US: Trade). Dimension: 235 x 155 x 6. Weight in Grams: 180. . 2012. Paperback. . . . . Seller Inventory # V9782817805146

Contact seller

Buy New

£ 143.38
Convert currency
Shipping: £ 8.75
From Ireland to U.S.A.
Destination, rates & speeds

Quantity: 15 available

Add to basket

There are 4 more copies of this book

View all search results for this book